Fortis Healthcare Limited (FORTIS) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹774.55 (+0.12% day change)
Key ratios
- P/E ratio
- 56.13
- P/B ratio
- 6.06
- ROE (%)
- 10.53
- ROCE (%)
- 11.81
- Debt/Equity
- 0.35
- Dividend yield (%)
- 0.13
- Market cap (₹ Cr)
- 58,475.28
Forensic checks
Piotroski F-Score: 8/9 · Altman Z-Score: 5.94 · Beneish M-Score: -2.4
InvestSights quality score
62.9/100 — Above Average (descriptive data-driven composite; not a recommendation)
Management guidance track record
- Overall hospital occupancy: guided 70%, delivered 69% (FY25) — missed guidance
- Hospital business EBITDA margin: guided 20.5%, delivered 20.5% (FY25) — met guidance
Latest earnings call (Q2 FY27)
AI summary: The central signal is that Fortis has shifted from balance-sheet repair to a sizeable capacity-expansion cycle, while near-term profitability is becoming more dependent on execution and regulation. Hospital revenue grew 18.6%, occupancy reached 72%, and inpatient volume increased around 13%, but management expects FY27 hospital margin to remain around 22%, post-ESOP and…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.